ExLibris header image
SFX Logo
Title: The structure ofClostridium difficiletoxin A glucosyltransferase domain bound to Mn2+and UDP provides insights into glucosyltransferase activity and product release
Source:

Febs Journal [1742-464X] DUrzo, Nunzia yr:2012


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library Free Backfiles
GO
Full text available via Wiley Online Library Full Collection 2019
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. De, Namrata K. "Modeling host-pathogen interactions: H. sapiens as a host and C. difficile as a pathogen." Journal of molecular recognition 25.9 (2012): 474-485. Link to Full Text for this item Link to SFX for this item
2. Lyras, D. "Toxin B is essential for virulence of Clostridium difficile." Nature 458.7242 (2009): 1176-1179. Link to Full Text for this item Link to SFX for this item
3. Lanis, Jordi M. "TcdB from hypervirulent Clostridium difficile exhibits increased efficiency of autoprocessing." Molecular microbiology 84.1 (2012): 66-76. Link to Full Text for this item Link to SFX for this item
4. Govind, R. "Secretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdE." PLOS pathogens 8.6 (2012): 1-. Link to Full Text for this item Link to SFX for this item
5. Reinert, Dirk J J. "Structural basis for the function of Clostridium difficile toxin B." Journal of molecular biology 351.5 (2005): 973-81. Link to SFX for this item
6. Kuehne, Sarah A. "The role of toxin A and toxin B in Clostridium difficile infection." Nature 467.7316 (2010): 711-713. Link to Full Text for this item Link to SFX for this item
7. Shan, J. "Prophage carriage and diversity within clinically relevant strains of Clostridium difficile." Applied and environmental microbiology 78.17 (2012): 6027-34. Link to Full Text for this item Link to SFX for this item
8. Rupnik, M. "Clostridium difficile infection: new developments in epidemiology and pathogenesis." Nature Reviews. Microbiology 7.7 (2009): 526-36. Link to Full Text for this item Link to SFX for this item
9. Voth, Daniel E E. "Clostridium difficile Toxins: Mechanism of Action and Role in Disease." Clinical microbiology reviews 18.2 (2005): 247-63. Link to Full Text for this item Link to SFX for this item
10. McDonald, Eric C. "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe." Lancet, The 366.9491 (2005): 1079-84. Link to SFX for this item
11. El Feghaly, Rana E. "The molecular basis of Clostridium difficile disease and host response." Current opinion in gastroenterology Publish Ahead of Print.1 (2014): 1-9. Link to SFX for this item
12. Aubry, A. "Modulation of toxin production by the flagellar regulon in Clostridium difficile." Infection and immunity 80.10 (2012): 3521-32. Link to Full Text for this item Link to SFX for this item
13. Tüll, P. "Emergence of Clostridium difficile-associated disease in North America and Europe." Clinical microbiology and infection 12.6 (2006): 2-18. Link to Full Text for this item Link to SFX for this item
14. Jank, T. "Structure and mode of action of clostridial glucosylating toxins: the ABCD model." Trends in Microbiology 16.5 (2008): 222-229. Link to SFX for this item
15. Gerding, Dale N N. "An epidemic, toxin gene-variant strain of Clostridium difficile." New England Journal of Medicine, The 353.23 (2006): 2433-41. Link to SFX for this item
16. Guo, B. "Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease." Alimentary pharmacology & therapeutics 35.8 (2012): 865-875. Link to Full Text for this item Link to SFX for this item
17. Seok, H. "Clostridium difficile Toxin A Inhibits the Kinase Activity of Extracellular Signal-Related Kinases 1 and 2 Through Direct Binding." Journal of microbiology and biotechnology 22.2 (2012): 170-175. Link to SFX for this item
18. Dumyati, G. "Community-associated Clostridium difficile Infections, Monroe County, New York, USA." Emerging infectious diseases 18.3 (2012): 392-400. Link to Full Text for this item Link to SFX for this item
19. Borde, A. "Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation." European journal of pharmaceutics and biopharmaceutics 79.3 (2011): 508-518. Link to SFX for this item
20. L, Alcala. "Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens." Journal of clinical microbiology 46.11 (2008): 3833-3835. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced